| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050546985 |
| P356 | DOI | 10.1186/1471-2202-3-19 |
| P932 | PMC publication ID | 137588 |
| P698 | PubMed publication ID | 12437765 |
| P5875 | ResearchGate publication ID | 11029779 |
| P50 | author | Hasan DeMirci | Q64840196 |
| P2093 | author name string | J David Clark | |
| Jelveh Lameh | |||
| Parham Gharagozlou | |||
| P2860 | cites work | Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity | Q31963231 |
| In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. | Q33942471 | ||
| Xorphanol | Q34199927 | ||
| Physical dependence induced by opiate partial agonists in the rat | Q34248622 | ||
| International Union of Pharmacology. XII. Classification of opioid receptors. | Q34412242 | ||
| Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. | Q34727185 | ||
| Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. | Q34749980 | ||
| Pharmacological mechanisms of opioid analgesics. | Q39496101 | ||
| Clinical pharmacokinetics of the newer intravenous anaesthetic agents | Q39545799 | ||
| Molecular biology of opioid receptors | Q40386755 | ||
| Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. | Q41082085 | ||
| Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells | Q41290918 | ||
| Purine involvement in morphine antinociception | Q41744393 | ||
| Characterization of novel benzodiazepine ligands in Spodotera frugiperda (Sf-9) insect cells | Q42053936 | ||
| Differential effects of prazosin and yohimbine on fentanyl-induced muscular rigidity in rats | Q42189030 | ||
| Involvement of locus coeruleus and noradrenergic neurotransmission in fentanyl-induced muscular rigidity in the rat. | Q42189795 | ||
| Attenuation of the fentanyl-induced muscle rigidity by the selective 5HT1A agonist 8-OH-DPAT. | Q42275959 | ||
| Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80. | Q42523672 | ||
| Involvement of cerulospinal glutamatergic neurotransmission in fentanyl-induced muscular rigidity in the rat. | Q42545816 | ||
| Opioid-induced rigidity after intravenous fentanyl | Q42549379 | ||
| delta-Opioid receptors are more efficiently coupled to adenylyl cyclase than to L-type Ca(2+) channels in transfected rat pituitary cells | Q44333489 | ||
| Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice | Q44333988 | ||
| Molecular determinants of non-specific recognition of delta, mu, and kappa opioid receptors | Q44334579 | ||
| Differentiation of delta, mu, and kappa opioid receptor agonists based on pharmacophore development and computed physicochemical properties | Q44335475 | ||
| Cyclic AMP mediates mu and delta, but not kappa opioid analgesia in the spinal cord of the rat. | Q44338070 | ||
| A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration | Q44339048 | ||
| The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats | Q44352759 | ||
| Selective opioid delta agonists elicit antinociceptive supraspinal/spinal synergy in the rat. | Q44352974 | ||
| Actions of opioids on respiratory activity via activation of brainstem mu-, delta- and kappa-receptors; an in vitro study | Q48536754 | ||
| Unraveling the identity of benzodiazepine binding sites in rat hipppocampus and olfactory bulb | Q60690948 | ||
| Antinociceptive actions of BW373U86 in the mouse | Q60728162 | ||
| Further evidence that naloxone acts as an inverse opiate agonist: implications for drug dependence and withdrawal | Q71219901 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 19 | |
| P577 | publication date | 2002-11-18 | |
| P1433 | published in | BMC Neuroscience | Q15766477 |
| P1476 | title | Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors | |
| P478 | volume | 3 |
| Q24540272 | Activity of opioid ligands in cells expressing cloned mu opioid receptors |
| Q92562255 | Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids |
| Q37661067 | Dezocine exhibits antihypersensitivity activities in neuropathy through spinal μ-opioid receptor activation and norepinephrine reuptake inhibition |
| Q48229162 | Effect of intravenous dezocine on fentanyl-induced cough during general anesthesia induction: a double-blinded, prospective, randomized, controlled trial |
| Q48136146 | Effects of pretreatment with a small dose of dexmedetomidine on sufentanil-induced cough during anesthetic induction. |
| Q37397149 | Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade |
| Q35005640 | Pharmacogenetics of new analgesics |
| Q38055713 | Pharmacokinetics of non-intravenous formulations of fentanyl |
| Q21262017 | Pharmacological profiles of opioid ligands at kappa opioid receptors |
| Q37376376 | The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake |
Search more.